Computed Tomography Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32


MARKETRESEARCH

Uploaded on Jan 18, 2024

According to the latest research report by IMARC Group, The global computed tomography market size reached US$ 4.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.4 Billion by 2032, exhibiting a growth rate (CAGR) of 5.27% during 2024-2032. More Info:- https://www.imarcgroup.com/computed-tomography-market

Comments

                     

Computed Tomography Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32

Global Computed Tomography Market Research and Forecast Report 2024-2032 Format: PDF+EXCEL © 2023 IMARC All Rights Reserved About IMARC Group In ternat ional Market Analys is Research and Consul t ing Group is a leading adv iser on management s t rategy and market research wor ldwide. We par tner wi th c l ients in a l l regions and indust ry vert ica ls to ident i fy thei r h ighest -value oppor tuni t ies, address thei r most cr i t ica l chal lenges, and t ransform thei r bus inesses. IMARC’s in format ion products inc lude major market , sc ient i f ic , economic and technological developments for bus iness leaders in pharmaceut ica l , indust r ia l , and h igh technology organizat ions. Market forecasts and indust ry analys is for b iotechnology, advanced mater ia ls , chemicals , food and beverage, t ravel and tour ism, nanotechnology and novel process ing methods are at the top of the company’s exper t ise. IMARC’s ta i lored approach combines unfathomable ins ight in to the dynamics o f companies and markets wi th c lose cooperat ion at a l l levels of the c l ient organizat ion. This ensures that our c l ients achieve unmatchable compet i t ive advantage, bui ld more pro f ic ient organizat ions, and secure las t ing resul ts . A cc o r d i ng t o t h e l a t e s t r e po r t b y I M A R C Gr o u p , t i t l e d " C o m p u t e d T o m o g r a p h y Ma r k e t : G l o b a l I n d u s t r y T r e n d s , S h a r e , S i z e , Gr o w th , O p p o r t u n i t y a n d F o r e c as t 2 0 2 4 - 20 3 2 , " t h e g l o b a l c o m p u t e d t om o g r ap h y ma r k e t s i z e r e a c h ed U S $ 4 . 7 B i l l i o n i n 2 02 3 . C om p u te d t om o g ra p h y ( C T ) r e f e r s t o a m e d i ca l i m ag i n g te c h n i q u e t h a t u t i l i z e s X - r ay s Report t o p r od u c e d e t a i l ed c r o s s - se c t i o n a l i ma g e s o f t h e b o d y . I t i s c o mp r i s e d o f s e v e ra l co m p o ne n t s , s u c h a s a n X - ra y t u b e , d e t ec t o rs , ga n t r y , p a t i e n t t a b l e , da t a a c q u i s i t i on sy s t e m ( D A S ) , i m a g e p r o ce s s i n g a n d s t o r a g e , c on s o l e , a n d us e r i n t e r f a c e . C om p u t ed Highlight and t om o g r ap h y i s w i d e l y u se d fo r d i a g no s i s , c a nc e r d e t e c t i o n , e me r g e n cy me d i c i n e , i n te r v e n t i o n a l p r o c e d u r e s , v i r t u a l e n d o s co p y , o r t h o p ed i c s , a n d c a rd i o v a sc u l a r i ma g i n g . A s co m p a r e d t o t r a d i t i o n a l X - r a y i ma g i n g , C T i s a s a f e , r e l i a b l e , a n d h i g h l y e f f i c i e n t Description t e c h n i q u e th a t o f f e r s b e t t e r v i s u a l i z a t i o n o f o r g a ns , b on e s , b l oo d v e s se l s , an d s o f t t i s su e s . I t ca n a l so g e ne r a t e i ma g e s i n m u l t i p l e p l a n es , i n c l u d i n g a x i a l , s a g i t t a l , a nd co r o n a l v i ew s , w h i c h e na b l e s h e a l th c a r e p ro f e s s i o n a l s t o e x a m i ne s t r uc t u r e s f r o m d i f f e r e n t a n g l es f o r a c c u ra t e d i ag n o s i s a n d t re a t m en t p l an n i n g . R eq u e s t f o r a P D F sa m p le o f th i s r ep o r t : h t t p s : / /w w w . i ma r c g r o u p . co m / co m p u te d - t o mo g r ap h y - ma r k e t / r e q u e s t s a mp l e Report Description G lo b a l C o m p u t e d T o m o g r a p h y M a r k e t T r e n d s : T h e e s c a l a t i n g p r e v a l e n c e o f c h r o n i c c o n d i t i o n s , s u c h a s c a n c e r , c a r d i o v a s c u l a r d i s e a s e s ( C V D s ) , a n d n e u r o l o g i c a l d i s o r d e r s , i s p r o p e l l i n g t h e m a r k e t g r o w t h . C T i s w i d e l y u s e d f o r t h e d i a g n o s i s , s t a g i n g , a n d m o n i t o r i n g o f d i s e a s e s , w h i c h a i d s h e a l t h c a r e p r o f e s s i o n a l s i n d e c i s i o n - m a k i n g a n d i m p r o v i n g c l i n i c a l o u t c o m e s . A l o n g w i t h t h i s , t h e r i s i n g g e r i a t r i c p o p u l a t i o n , w h i c h i s h i g h l y s u s c e p t i b l e t o d e v e l o p i n g c h r o n i c i l l n e s s e s , i s a c t i n g a s a n o t h e r g r o w t h - i n d u c i n g f a c t o r . F u r t h e r m o r e , t h e g r o w i n g a w a r e n e s s a m o n g t h e m a s s e s r e g a r d i n g e a r l y d i s e a s e d i a g n o s i s t o p r e v e n t f u t u r e c o m p l i c a t i o n s , e n a b l e e a r l y i n t e r v e n t i o n , a n d r e d u c e h e a l t h c a r e e x p e n d i t u r e i s p r o v i d i n g a b o o s t t o t h e m a r k e t g r o w t h . A d d i t i o n a l l y , t h e r e c e n t d e v e l o p m e n t o f p h o t o n - c o u n t i n g d e t e c t o r s t h a t i m p r o v e s p e c t r a l i m a g i n g , m a t e r i a l d e c o m p o s i t i o n , a n d r e d u c e r a d i a t i o n d o s e b y o p t i m i z i n g e n e r g y - s p e c i f i c i m a g i n g i s c o n t r i b u t i n g t o t h e m a r k e t g r o w t h . B e s i d e s t h i s , t h e i n t r o d u c t i o n o f d u a l - e n e r g y c o m p u t e d t o m o g r a p h y , w h i c h u t i l i z e s d i f f e r e n t l e v e l s o f X - r a y s t o p r o v i d e a d d i t i o n a l i n f o r m a t i o n a b o u t t i s s u e c o m p o s i t i o n a n d c h a r a c t e r i s t i c s , i s p o s i t i v e l y i n f l u e n c i n g t h e m a r k e t g r o w t h . A p a r t f r o m t h i s , t h e i m p l e m e n t a t i o n o f s u p p o r t i v e g o v e r n m e n t p o l i c i e s t o s p r e a d a w a r e n e s s r e g a r d i n g c h r o n i c i l l n e s s e s a n d p r o v i d e a c c e s s t o h i g h - q u a l i t y t r e a t m e n t s i s f a v o r i n g t h e m a r k e t g r o w t h . O t h e r f a c t o r s , i n c l u d i n g i n c r e a s i n g d e m a n d f o r m i n i m a l l y i n v a s i v e ( M I ) p r o c e d u r e s , r i s i n g i n v e s t m e n t s i n t h e d e v e l o p m e n t o f a d v a n c e d C T s c a n n e r s , a n d t h e g r o w i n g n u m b e r o f h e a l t h c a r e f a c i l i t i e s , s u c h a s h o s p i t a l s a n d c l i n i c s , a r e a n t i c i p a t e d t o d r i v e t h e m a r k e t g r o w t h . L o o k in g f o r w a r d , t h e m a r k e t i s e x p e c t e d t o r e a c h U S $ 7 . 4 B i l l i o n b y 2 0 3 2 , e x h i b i t i n g a C A G R o f 5 . 2 7 % d u r i n g 2 0 2 4 - 2 0 3 2 . V ie w R e p o r t T O C , F i g u r e s a n d T a b l e s : h t t p s : / / w w w . i m a r c g r o u p . c o m / c o m p u t e d - t o m o g r a p h y - m a r k e t Type Insights: • Low Sl ice • Medium Sl ice • High Sl ice • Cone Beam Report Application Insights: Segmentation • Oncology • Neurology • Cardiovascular • Musculoskeletal • Others End User Insights: • Hospitals • Diagnost ic Centers • Others Report Regional Insights: Segmentation • North America • Europe • Asia-Pacifi c • Latin America • Middle East and Afr ica • Canon Medical Systems Corporation (Canon Inc.) • FUJIFILM Holdings Corporation • GE HealthCare (General Electric Company) Competitive • Koning Corporation Landscape • Koninkli jke Phi l ips N.V. • NeuroLogica Corp. (Samsung Electronics with Key Co. Ltd.) Players • Neusoft Medical Systems Co. Ltd. (Neusoft Corporation) • Planmeca Oy • Siemens Healthineers AG (Siemens AG) • Stryker Corporation How big is the global computed tomography market? What is the expected growth rate of the global computed tomography market during 2024-2032? What are the key factors driving the global computed tomography market? Key What has been the impact of COVID-19 on the global Questions computed tomography market? Answered in What is the breakup of the global computed tomography market based on the type? the Report What is the breakup of the global computed tomography market based on the application? What is the breakup of the global computed tomography market based on the end user? What are the key regions in the global computed tomography market? Who are the key players/companies in the global computed tomography market? 1 P r e f a c e 2 S c o p e a n d M e t h o d o l o g y 2 . 1 O b j e c t i v e s o f t h e S t u d y 2 . 2 S t a k e h o l d e r s 2 . 3 D a t a S o u r c e s 2 . 3 . 1 P r i m a r y S o u r c e s 2 . 3 . 2 S e c o n d a r y S o u r c e s 2 . 4 M a r k e t E s t i m a t i o n Table of 2 . 4 . 1 B o t t o m - U p A p p r o a c h2 . 4 . 2 T o p - D o w n A p p r o a c h 2 . 5 F o r e c a s t i n g M e t h o d o l o g y 3 E x e c u t i v e S u m m a r y 4 G l o b a l C o m p u t e d T o m o g r a p h y M a r k e t - I n t r o d u c t i o n Contents 4 . 1 O v e r v i e w4 . 2 M a r k e t D y n a m i c s 4 . 3 I n d u s t r y T r e n d s 4 . 4 C o m p e t i t i v e I n t e l l i g e n c e 5 G l o b a l C o m p u t e d To m o g r a p h y M a r k e t L a n d s c a p e 5 . 1 H i s t o r i c a l a n d C u r r e n t M a r k e t Tr e n d s ( 2 0 1 8 - 2 0 2 3 ) 5 . 2 M a r k e t F o r e c a s t ( 2 0 2 4 - 2 0 3 2 ) 6 G l o b a l C o m p u t e d T o m o g r a p h y M a r k e t - B r e a k u p b y T y p e 6 . 1 L o w S l i c e 6 . 1 . 1 O v e r v i e w 6 . 1 . 2 H i s t o r i c a l a n d C u r r e n t M a r k e t T r e n d s ( 2 0 1 8 - 2 0 2 3 ) 6 . 1 . 3 M a r k e t S e g m e n t a t i o n 6 . 1 . 4 M a r k e t F o r e c a s t ( 2 0 2 4 - 2 0 3 2 ) 6 . 2 M e d i u m S l i c e 6 . 2 . 1 O v e r v i e w 6 . 2 . 2 H i s t o r i c a l a n d C u r r e n t M a r k e t T r e n d s ( 2 0 1 8 - 2 0 2 3 ) 6 .2 . 3 Ma rke t Segm ent a t i o n 6 .2 . 4 Ma rke t Fo rec a s t ( 202 4 -20 32 ) 6.3 H igh S l i ce 6 .3 . 1 Ov e rv i ew 6 .3 . 2 H i s to r i c a l a nd C urren t Ma rke t Trends (2 018 -202 3 ) 6 .3 . 3 Ma rke t Segm ent a t i o n 6 .3 . 4 Ma rke t Fo rec a s t ( 202 4 -20 32 ) 6.4 Cone Beam 6 .4 . 1 Ov e rv i ew Table of 6 .4 . 2 H i s to r i c a l a nd C urren t Ma rke t Trends (2 018 -202 3 )6 .4 . 3 Ma rke t Segm ent a t i o n 6 .4 . 4 Ma rke t Fo rec a s t ( 202 4 -20 32 ) 6.5 Att ract ive Investment Propos i t ion by Type Contents 7 G l o b a l C o m p u t e d T o m o g r a p h y M a r k e t - B r e a k u p b y A p p l i c a t i o n 7 . 1 O n c o l o g y 7 . 1 . 1 O v e r v i e w 7 . 1 . 2 H i s t o r i c a l a n d C u r r e n t M a r k e t T r e n d s ( 2 0 1 8 - 2 0 2 3 ) 7 . 1 . 3 M a r k e t S e g m e n t a t i o n 7 . 1 . 4 M a r k e t F o r e c a s t ( 2 0 2 4 - 2 0 3 2 ) 7 . 2 N e u r o l o g y 7 . 2 . 1 O v e r v i e w 7 . 2 . 2 H i s t o r i c a l a n d C u r r e n t M a r k e t T r e n d s ( 2 0 1 8 - 2 0 2 3 ) 7 . 2 . 3 M a r k e t S e g m e n t a t i o n 7 . 2 . 4 M a r k e t F o r e c a s t ( 2 0 2 4 - 2 0 3 2 ) 7 . 3 C a r d i o v a s c u l a r 7 . 3 . 1 O v e r v i e w F o r m o r e i n f o r m a t i o n , v i s i t : ht t ps : / /w ww. i ma rc gro up . c o m /c om p uted - to m o gra phy-m a rke t / t o c Disclaimer © 2023 IMARC Al l R ights Reserved Th is Pub l i ca t ion and a l l i t ’ s con ten ts un less o therw ise men t i oned a re copy r i gh ted in the name o f I n t e rna t i ona l Marke t Ana lys i s Research and Consu l t ing ( IMARC) . No pa r t o f t h i s pub l i ca t ion may be rep roduced , repackaged , red i s t r i bu ted o r res o ld i n who le o r i n any pa r t . The pub l i ca t ion may a l so no t be used i n any f o rm o r by and means g raph i c e lec t ron ic o r mechan ic a l , i nc lud ing pho tocopy ing , reco rd ing , t ap ing o r by i n fo rmat i on s to rage o r re t r ieva l , o r by any o the r f o rm, w i t hou t the exp ress c ons en t o f I n t e rna t iona l Marke t Ana lys i s Research and Consu l t i ng ( IMARC) . Disc la imer : Al l con ten ts and da ta o f t h i s pub l i c a t i on , i nc lud ing fo recas t s , da ta ana lys i s and op in ion have been based on in f o rmat ion and sources be l ieved to be accu ra te and re l iab le a t t he t ime o f pub l i sh ing . In t e rna t i ona l Ma rke t Ana l ys is Research and Consu l t ing makes no rep resen ta t ion o f war ran t y o f any k ind as to t he acc u racy o r comp le teness o f any I n fo rmat i on p rov ided . IMARC accep ts no l i ab i l i t y wha tsoever f o r any los s o r damage resu l t i ng f rom op in ion , e r ro rs o r i naccu rac ies i f any f ound th is pub l i ca t ion . IMARC, IMARC Group and G loba l Therapy I ns igh t Ser i es a re reg is t e red t rademarks o f I n te rna t iona l Marke t Ana lys i s Research and Consu l t ing . A l l o the r t rademarks used i n th i s pub l i ca t i on a re reg i s te red t rademarks o f t he i r r espec t i ve compan ies . Contact Us Visit us at : https://www.imarcgroup.com TELEPHONE: +1-631-791-1145 E-MAIL: [email protected]